| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |